Book ID: CBB525075418

Drug War Pathologies: Embedded Corporatism and U.S. Drug Enforcement in the Americas (2019)

unapi

In this book, Horace Bartilow develops a theory of embedded corporatism to explain the U.S. government's war on drugs. Stemming from President Richard Nixon's 1971 call for an international approach to this "war," U.S. drug enforcement policy has persisted with few changes to the present day, despite widespread criticism of its effectiveness and of its unequal effects on hundreds of millions of people across the Americas. While researchers consistently emphasize the role of race in U.S. drug enforcement, Bartilow's empirical analysis highlights the class dimension of the drug war and the immense power that American corporations wield within the regime.Drawing on qualitative case study methods, declassified U.S. government documents, and advanced econometric estimators that analyze cross-national data, Bartilow demonstrates how corporate power is projected and embedded—in lobbying, financing of federal elections, funding of policy think tanks, and interlocks with the federal government and the military. Embedded corporatism, he explains, creates the conditions by which interests of state and nonstate members of the regime converge to promote capital accumulation. The subsequent human rights repression, illiberal democratic governments, antiworker practices, and widening income inequality throughout the Americas, Bartilow argues, are the pathological policy outcomes of embedded corporatism in drug enforcement.

...More
Reviewed By

Review Matthew DeCloedt (2020) Review of "Drug War Pathologies: Embedded Corporatism and U.S. Drug Enforcement in the Americas". Pharmacy in History (pp. 59-60). unapi

Citation URI
https://data.isiscb.org/isis/citation/CBB525075418/

Similar Citations

Book Nancy D. Campbell; (2020)
OD: Naloxone and the Politics of Overdose (/isis/citation/CBB601007525/)

Article McKeever, Brooke Weberling; (2013)
News Framing of Autism: Understanding Media Advocacy and the Combating Autism Act (/isis/citation/CBB001320108/)

Chapter Daemmrich, A.; Greene, J.; (2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance (/isis/citation/CBB001221031/)

Article Daemmrich, A.; (2007)
Pharmaceutical Regulation in the United States and Europe (/isis/citation/CBB001221028/)

Book Carsten Timmermann; (2020)
Moonshots at Cancer: The Roche Story (/isis/citation/CBB657158836/)

Book Holloway, Karla F. C.; (2011)
Private Bodies, Public Texts: Race, Gender, and a Cultural Bioethics (/isis/citation/CBB001200198/)

Thesis Levy, Jean Elizabeth; (2007)
Controlling the Course of Scientific Advance: The Case of Human Embryology (/isis/citation/CBB001560939/)

Chapter Hayden, Cori; (2011)
No Patent, No Generic: Pharmaceutical Access and the Politics of the Copy (/isis/citation/CBB001221561/)

Book David A. Guba Jr; (2020)
Taming Cannabis: Drugs and Empire in Nineteenth-Century France (/isis/citation/CBB831549564/)

Book Stephen Snelders; (2021)
Drug smuggler nation: Narcotics and the Netherlands, 1920–1995 (/isis/citation/CBB439238194/)

Authors & Contributors
Daemmrich, A.
Aikins, Ross D.
Matthew R. Pembleton
Guba, David A., Jr.
Biehl, Joao
Tovino, Stacey A.
Journals
Technology and Culture
Science Communication
Pharmacy in History
Osiris: A Research Journal Devoted to the History of Science and Its Cultural Influences
Korean Journal of Medical History
History of Education
Publishers
Editiones Roche
University of Texas Medical Branch Graduate School of Biomedical Science
University of Southampton (United Kingdom)
University of Massachusetts Press
MIT Press
McGill-Queen's University Press
Concepts
Pharmaceutical industry
Medicine and government
Medicine and law
Drug use
Legislative and administrative regulations
Therapeutic practice; therapy; treatment
Time Periods
20th century, late
21st century
20th century
20th century, early
19th century
Places
United States
Great Britain
Argentina
Netherlands
North Africa
Germany
Institutions
United States. Federal Bureau of Narcotics
United States. Food and Drug Administration
World Health Organization (WHO)
Comments

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment